Bausch + Lomb Corporation (BLCO) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Instruments & Supplies 산업에서 운영. 본사 소재지는 Vaughan, ON, 캐나다. 현재 CEO는 Brenton L. Saunders.
BLCO 을(를) 보유 IPO 날짜 2022-05-06, 13,500 명의 정규직 직원, 에 상장 NYSE, 시가총액 $5.92B.
Bausch + Lomb Corporation is a global eye health company founded in 1853 and headquartered in Vaughan, Canada. The company operates through three primary segments: Vision Care and Consumer Health Care, which includes contact lenses across all wearing modalities, lens care solutions, and over-the-counter eye care products; Ophthalmic Pharmaceuticals, offering both proprietary and generic medications for conditions such as glaucoma, ocular hypertension, and retinal diseases; and Surgical, which provides advanced surgical instruments, intraocular lenses, and equipment for cataract and retinal procedures. Together, these segments enable Bausch + Lomb to serve patients across the complete spectrum of eye health, from routine vision correction to complex surgical interventions.
